Indiana University School of Medicine scientists have identified a promising drug target for Alzheimer's disease. The team ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

The drug would need to be taken long before symptoms first appear—but it could be used to help protect at-risk individuals.

Scientists have found that the anti-seizure medication levetiracetam prevents the buildup of faulty amyloid-beta proteins in ...

The research found that mice with Alzheimer's disease symptoms improved when a certain brain protein was suppressed.

By far the strongest genetic risk factor for Alzheimer’s disease is a variant of apolipoprotein E, or ApoE. People who carry ...

New disease-modifying agents are being evaluated in the clinic that could change the course of treatment for Alzheimer’s disease patients. Regulated industries like pharmaceuticals, biotech, and ...

AI-powered gene maps reveal the hidden control centers driving Alzheimer’s disease — and point to new hope for treatment.

By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

Are you interested in lowering your risk of developing Alzheimer’s disease and other types of dementia? We can take actions ...

The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.